|
US8431713B2
(en)
|
2007-01-24 |
2013-04-30 |
Array Biopharma, Inc. |
2-aminopyridine derivatives as glucokinase activators
|
|
CA2681695A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Array Biopharma Inc. |
2-aminopyridine analogs as glucokinase activators
|
|
WO2009022171A1
(en)
*
|
2007-08-13 |
2009-02-19 |
Astrazeneca Ab |
Pyridinyiioxy pyridines as alk5 inhibitors
|
|
WO2009022179A2
(en)
*
|
2007-08-14 |
2009-02-19 |
Astrazeneca Ab |
Glucokinase activators in the treatment of osteoarthritis
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
UA101166C2
(ru)
|
2007-09-21 |
2013-03-11 |
Аррей Биофарма Инк. |
Производные пиридин-2-иламино-1,2,4-тиадиазола как активаторы глюкокиназы для лечения сахарного диабета
|
|
EA201000561A1
(ru)
|
2007-10-09 |
2010-10-29 |
Мерк Патент Гмбх |
Производные пиридина, пригодные в качестве активаторов глюкокиназы
|
|
US8558000B2
(en)
|
2008-01-23 |
2013-10-15 |
Bristol-Myers Squibb Company |
4-pyridinone compounds and their use for cancer
|
|
US7741327B2
(en)
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
|
KR20110070887A
(ko)
|
2008-10-02 |
2011-06-24 |
레스피버트 리미티드 |
Ｐ38 엠에이피 키나제 억제제
|
|
JPWO2010058846A1
(ja)
|
2008-11-21 |
2012-04-19 |
アステラス製薬株式会社 |
４，６−ジアミノニコチンアミド化合物
|
|
JP5670912B2
(ja)
|
2008-12-11 |
2015-02-18 |
レスピバート・リミテツド |
ｐ３８ＭＡＰキナーゼ阻害剤
|
|
GB0905955D0
(en)
|
2009-04-06 |
2009-05-20 |
Respivert Ltd |
Novel compounds
|
|
GB0921730D0
(en)
|
2009-12-11 |
2010-01-27 |
Respivert Ltd |
Method of treatment
|
|
GB0921731D0
(en)
|
2009-12-11 |
2010-01-27 |
Respivert Ltd |
Theraputic uses
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2553086B1
(en)
|
2010-03-31 |
2017-04-19 |
The Scripps Research Institute |
Reprogramming cells
|
|
GB201005589D0
(en)
|
2010-04-01 |
2010-05-19 |
Respivert Ltd |
Novel compounds
|
|
EP2556067B1
(en)
|
2010-04-08 |
2016-02-24 |
Respivert Limited |
Pyrazolyl ureas as p38 map kinase inhibitors
|
|
EP2556068B1
(en)
|
2010-04-08 |
2019-01-23 |
Respivert Limited |
P38 map kinase inhibitors
|
|
US8178689B2
(en)
|
2010-06-17 |
2012-05-15 |
Hoffman-La Roche Inc. |
Tricyclic compounds
|
|
US8933024B2
(en)
|
2010-06-18 |
2015-01-13 |
Sanofi |
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
HUE037860T2
(hu)
*
|
2010-11-19 |
2018-09-28 |
Ligand Pharm Inc |
Heterociklusos aminok és alkalmazásuk
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120054A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8710050B2
(en)
|
2011-03-08 |
2014-04-29 |
Sanofi |
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
JPWO2012121314A1
(ja)
*
|
2011-03-09 |
2014-07-17 |
第一三共株式会社 |
ジピリジルアミン誘導体
|
|
CN102786517B
(zh)
*
|
2011-05-18 |
2017-06-06 |
中国医学科学院药物研究所 |
Gk和ppar双重激动活性的嘧啶噻唑胺类衍生物
|
|
JP5748210B2
(ja)
*
|
2011-05-26 |
2015-07-15 |
日本化薬株式会社 |
複素環化合物の製造方法
|
|
EA031153B1
(ru)
|
2011-06-10 |
2018-11-30 |
Мерк Патент Гмбх |
Применение пиримидиновых соединений с btk ингибирующей активностью
|
|
EP2754654B1
(en)
*
|
2011-09-05 |
2018-05-30 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing coumarin derivative
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013086397A1
(en)
*
|
2011-12-08 |
2013-06-13 |
Array Biopharma Inc. |
Urea compounds as gka activators
|
|
US9296735B2
(en)
|
2012-05-18 |
2016-03-29 |
Amgen Inc. |
Method for the preparation of thiadiazoles
|
|
US9546153B2
(en)
*
|
2012-11-08 |
2017-01-17 |
Bristol-Myers Squibb Company |
Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
|
|
WO2014076484A1
(en)
|
2012-11-16 |
2014-05-22 |
Respivert Limited |
Kinase inhibitors
|
|
US20160031874A1
(en)
|
2013-03-13 |
2016-02-04 |
The Broad Institute, Inc. |
Substituted aminothiazoles for the treatment of tuberculosis
|
|
WO2016001341A1
(en)
*
|
2014-07-03 |
2016-01-07 |
F. Hoffmann-La Roche Ag |
Sulfonylaminopyridine compounds, compositions and methods of use
|
|
CN104610143A
(zh)
*
|
2015-02-12 |
2015-05-13 |
佛山市赛维斯医药科技有限公司 |
一种含硝基喹啉结构的葡萄糖激酶活化剂及其用途
|
|
JP6483272B2
(ja)
*
|
2015-02-17 |
2019-03-13 |
グアンジョウ インスティテュート オブ バイオメディスン アンド ヘルス，チャイニーズ アカデミー オブ サイエンスィズ |
白色脂肪組織の褐色化を誘導するための化合物および方法
|
|
US10807983B2
(en)
|
2015-03-16 |
2020-10-20 |
Ligand Pharmaceuticals, Inc. |
Imidazo-fused heterocycles and uses thereof
|
|
CN107690429B
(zh)
*
|
2015-04-07 |
2022-02-25 |
Ela制药有限公司 |
用于治疗和/或预防细胞或组织坏死的组合物，其特异性靶向组织蛋白酶c和/或cela1和/或cela3a和/或与其结构相关的酶
|
|
CA2988405A1
(en)
|
2015-06-11 |
2016-12-15 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
P62-zz chemical inhibitor
|
|
US10894784B2
(en)
|
2015-12-18 |
2021-01-19 |
Bayer Pharma Aktiengesellschaft |
Heteroarylbenzimidazole compounds
|
|
WO2017207534A1
(en)
|
2016-06-03 |
2017-12-07 |
Bayer Pharma Aktiengesellschaft |
Substituted heteroarylbenzimidazole compounds
|
|
CN115448916B
(zh)
*
|
2016-10-14 |
2026-04-28 |
武田药品工业株式会社 |
Tyk2抑制剂及其用途
|
|
EP3846793B1
(en)
|
2018-09-07 |
2024-01-24 |
PIC Therapeutics, Inc. |
Eif4e inhibitors and uses thereof
|
|
CN113993859B
(zh)
*
|
2019-06-25 |
2024-07-02 |
益方生物科技(上海)股份有限公司 |
杂环化合物、其制备方法及其使用方法
|
|
CN110898049B
(zh)
*
|
2019-11-29 |
2021-09-14 |
华中师范大学 |
二硫化合物在制备药物中的应用、fbp酶抑制剂及用于预防和/或治疗糖尿病的药剂
|
|
MX2022010944A
(es)
|
2020-03-03 |
2022-11-09 |
Pic Therapeutics Inc |
Inhibidores del factor de iniciacion de traduccion eucariotica 4e (eif4e) y sus usos.
|
|
WO2022147694A1
(en)
*
|
2021-01-06 |
2022-07-14 |
Beijing Erai Therapeutics Co., Ltd. |
Aminoheteroaryl compounds and uses thereof
|
|
JP2024532276A
(ja)
|
2021-08-25 |
2024-09-05 |
ピク セラピューティクス， インコーポレイテッド |
ｅＩＦ４Ｅ阻害剤及びその使用
|
|
TW202315621A
(zh)
|
2021-08-25 |
2023-04-16 |
美商皮克醫療公司 |
Ｅｉｆ４ｅ抑制劑及其用途
|